|

Arthritis Clinical Trials in Raleigh, NC

28 recruiting studies within 50 miles

Phase
Trial Phase Dist.
SakuraBead Used as Resorbable Embolic for Genicular Artery EmbolizationN/A<1 mi
Embo Registry; National Registry for Artery Embolization—8 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)—11 mi
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications—11 mi
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement SystemN/A11 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—21 mi
Improving Hypertension Control in Rheumatoid ArthritisN/A21 mi
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)Phase 121 mi
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid ArthritisN/A21 mi
Exactech Shoulder Post Market Clinical Follow-up Study—21 mi
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF StudyN/A21 mi
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic—21 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 321 mi
Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block—21 mi
SMR Stemless Reverse Vs SMR Reverse Shoulder SystemN/A21 mi
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only—21 mi
Maternal Autoimmune Disease Research Alliance (MADRA) Registry—21 mi
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesPhase 121 mi
Gait Rehabilitation to Treat FastOAN/A25 mi
Addressing Neuromuscular Deficits for Improved Outcomes in Ankle RehabilitationN/A25 mi
The Osteoarthritis Prevention StudyN/A25 mi
Preventing Injured Knees From osteoArthritis: Severity OutcomesPhase 225 mi
Knee Biofeedback Rehabilitation Through Game TherapyN/A25 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 325 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A25 mi
Vibration and Post-traumatic Osteoarthritis Risk Following ACL InjuryN/A25 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Phase 125 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 125 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.